6533b839fe1ef96bd12a6df0

RESEARCH PRODUCT

Add-on Peginterferon Alfa-2a significantly reduces HBsAg levels in chronic hepatitis B, HBeAg-negative, genotype D patients fully suppressed on nucleot(s)ide analogues treatment: HERMES Study Interim Analysis

Mario RizzettoAntonio CraxìG.b. GaetaMaria Chiara ColomboMaurizia Rossana BrunettoG. PalmieriPietro Lampertico

subject

HBsAgHepatologyChronic hepatitisHbeag negativebusiness.industryGenotypeGastroenterologymedicinebusinessInterim analysisVirologyPeginterferon alfa-2amedicine.drughttps://doi.org/10.1016/j.dld.2015.01.064